• 1. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 2. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 3. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyridines Pyrrolopyridines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyridines

Introduction to (1H-Pyrrolo[3,2-b]pyridin-2-yl)methanamine and Its Significance in Modern Chemical Biology

The compound with the CAS number 1245808-67-6 is a fascinating molecule known as (1H-Pyrrolo[3,2-b]pyridin-2-yl)methanamine. This heterocyclic amine derivative has garnered significant attention in the field of chemical biology due to its unique structural properties and potential biological activities. The pyrrolopyridine scaffold, a fused ring system consisting of a pyrrole and a pyridine ring, is a privileged structure in drug discovery, often exhibiting remarkable binding affinity and selectivity towards various biological targets.

In recent years, the exploration of such heterocyclic compounds has been intensified, particularly in the quest for novel therapeutic agents. The presence of nitrogen atoms in both the pyrrole and pyridine rings contributes to the compound's versatility, enabling it to interact with a wide range of biological receptors and enzymes. This structural feature has made (1H-Pyrrolo[3,2-b]pyridin-2-yl)methanamine a valuable scaffold for designing molecules with potential applications in pharmacology.

One of the most compelling aspects of this compound is its potential role as a precursor in the synthesis of more complex bioactive molecules. Researchers have been leveraging its structural framework to develop inhibitors targeting various disease-related pathways. For instance, studies have suggested that derivatives of this compound may exhibit inhibitory effects on kinases and other enzymes involved in cancer progression. The methanamine group at the 2-position of the pyrrolopyridine ring provides a handle for further functionalization, allowing chemists to tailor the molecule's properties to specific biological needs.

The significance of (1H-Pyrrolo[3,2-b]pyridin-2-yl)methanamine is further underscored by its incorporation into several ongoing research projects aimed at addressing unmet medical needs. In particular, its ability to modulate protein-protein interactions has made it a candidate for developing treatments against neurological disorders. The compound's interaction with neurotransmitter receptors and ion channels has been a focus of interest, with preliminary data suggesting promising results in preclinical models.

From a synthetic chemistry perspective, the synthesis of (1H-Pyrrolo[3,2-b]pyridin-2-yl)methanamine presents an intriguing challenge. The construction of the pyrrolopyridine core requires sophisticated methodologies that often involve multi-step reactions and careful control of reaction conditions. Advances in catalytic systems and transition metal chemistry have enabled more efficient routes to this scaffold, making it more accessible for medicinal chemists. These synthetic advancements are crucial for accelerating the discovery and development of novel derivatives with enhanced pharmacological properties.

The compound's potential is also reflected in its role as an intermediate in the production of more complex molecules with therapeutic applications. For example, researchers have explored its use in generating libraries of small molecules for high-throughput screening campaigns. These libraries are instrumental in identifying lead compounds that can be further optimized for specific therapeutic targets. The versatility of (1H-Pyrrolo[3,2-b]pyridin-2-yl)methanamine as a building block makes it an indispensable tool in modern drug discovery pipelines.

In conclusion, (1H-Pyrrolo[3,2-b]pyridin-2-yl)methanamine, with its CAS number 1245808-67-6, represents a significant advancement in the field of chemical biology. Its unique structural features and potential biological activities make it a valuable candidate for further exploration and development. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in the discovery and design of novel therapeutic agents.

• 267876-26-6(5-Aminomethyl-4-azaindole)
• 4943-67-3(5-Methyl-1H-pyrrolo3,2-bpyridine)
• 867035-40-3(1H-pyrrolo[2,3-c]pyridin-2-ylmethanamine;dihydrochloride)
• 438571-18-7(1H-pyrrolo[3,2-c]pyridin-2-ylmethanamine)
• 267876-19-7(1H-pyrrolo[2,3-c]pyridin-5-ylmethanamine)
• 885271-04-5((1,6-NAPHTHYRIDIN-2-YL)METHANAMINE)
• 267876-20-0(1-(1h-pyrrolo[3,2-b]pyridin-5-yl)methanamine Dihydrochloride)
• 867140-61-2((1H-Pyrrolo[2,3-c]pyridin-2-yl)methanamine)
• 73177-35-2(2-Methyl-1H-pyrrolo[3,2-b]pyridine)
• 1432754-34-1((1H-Pyrrolo[3,2-b]pyridin-5-yl)methanamine hydrochloride)